Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability

Neuron

Volumn 38, Issue 3, 2003, Pages 461-472

  Chevaleyre, Vivien ^a   Castillo, Pablo E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; CANNABINOID DERIVATIVE; GLUTAMATE RECEPTOR; METABOTROPIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DEPRESSION; GABAERGIC SYSTEM; LEARNING; LONG TERM POTENTIATION; MEMORY; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SYNAPSE; SYNAPTIC POTENTIAL;

EID: 0037986346     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00235-6     Document Type: Article

References (68)

1. Abraham W.C., Gustafsson B., Wigstrom H. Long-term potentiation involves enhanced synaptic excitation relative to synaptic inhibition in guinea-pig hippocampus. J. Physiol. 394:1987;367-380.
2. Anwyl R. Metabotropic glutamate receptors. electrophysiological properties and role in plasticity Brain Res. Brain Res. Rev. 29:1999;83-120.
3. Belan P.V., Kostyuk P.G. Glutamate-receptor-induced modulation of GABAergic synaptic transmission in the hippocampus. Pflugers Arch. 444:2002;26-37.
4. Bernard C., Wheal H.V. Expression of EPSP/spike potentiation following low frequency and tetanic stimulation in the CA1 area of the rat hippocampus. J. Neurosci. 15:1995;6542-6551.
5. Bliss T.V., Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232:1973;331-356.
6. Breakwell N.A., Rowan M.J., Anwyl R. Metabotropic glutamate receptor dependent EPSP and EPSP-spike potentiation in area CA1 of the submerged rat hippocampal slice. J. Neurophysiol. 76:1996;3126-3135.
7. Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Vogt L.J., Sim-Selley L.J. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J. Neurochem. 73:1999;2447-2459.
8. Caillard O., Ben-Ari Y., Gaiarsa J.L. Long-term potentiation of GABAergic synaptic transmission in neonatal rat hippocampus. J. Physiol. 518:1999;109-119. a.
9. Caillard O., Ben-Ari Y., Gaiarsa J.-L. Mechanisms of induction and expression of long-term depression at GABAergic synapses in the neonatal rat hippocampus. J. Neurosci. 19:1999;7568-7577. b.
10. Caillard O., Ben-Ari Y., Gaiarsa J.L. Activation of presynaptic and postsynaptic ryanodine-sensitive calcium stores is required for the induction of long-term depression at GABAergic synapses in the neonatal rat hippocampus. J. Neurosci. 20:2000;RC94.
11. Carlson G., Wang Y., Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 5:2002;723-724.
12. Chavez-Noriega L.E., Bliss T.V., Halliwell J.V. The EPSP-spike (E-S) component of long-term potentiation in the rat hippocampal slice is modulated by GABAergic but not cholinergic mechanisms. Neurosci. Lett. 104:1989;58-64.
13. Collins D.R., Pertwee R.G., Davies S.N. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid- mediated blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol. 115:1995;869-870.
14. Cope D.W., Maccaferri G., Marton L.F., Roberts J.D., Cobden P.M., Somogyi P. Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience. 109:2002;63-80.
15. Davies C.H., Collingridge G.L. The physiological regulation of synaptic inhibition by GABAB autoreceptors in rat hippocampus. J. Physiol. 472:1993;245-265.
16. Deisz R.A., Prince D.A. Frequency-dependent depression of inhibition in guinea-pig neocortex in vitro by GABAB receptor feed-back on GABA release. J. Physiol. 412:1989;513-541.
17. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
18. Dingledine R., Gjerstad L. Reduced inhibition during epileptiform activity in the in vitro hippocampal slice. J. Physiol. 305:1980;297-313.
19. Gaiarsa J.L., Caillard O., Ben-Ari Y. Long-term plasticity at GABAergic and glycinergic synapses. mechanisms and functional significance Trends Neurosci. 25:2002;564-570.
20. Gerdeman G.L., Ronesi J., Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5:2002;446-451.
21. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2:1999;358-363.
22. Glaum S.R., Brooks P.A. Tetanus-induced sustained potentiation of monosynaptic inhibitory transmission in the rat medulla. evidence for a presynaptic locus J. Neurophysiol. 76:1996;30-38.
23. Hajos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12:2000;3239-3249.
24. Holmgren C.D., Zilberter Y. Coincident spiking activity induces long-term changes in inhibition of neocortical pyramidal cells. J. Neurosci. 21:2001;8270-8277.
25. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R.et al. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:2002;161-202.
26. Irving A.J., Coutts A.A., Harvey J., Rae M.G., Mackie K., Bewick G.S., Pertwee R.G. Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience. 98:2000;253-262.
27. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19:1999;4544-4558.
28. Katz L.C., Shatz C.J. Synaptic activity and the construction of cortical circuits. Science. 274:1996;1133-1138.
29. 2+ release are involved in the induction of long-term potentiation at visual cortical inhibitory synapses. J. Neurosci. 16:1996;6342-6352.
30. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron. 29:2001;717-727.
31. Kreitzer A.C., Regehr W.G. Retrograde signaling by endocannabinoids. Curr. Opin. Neurobiol. 12:2002;324-330.
32. Lichtman A.H., Varvel S.A., Martin B.R. Endocannabinoids in cognition and dependence. Prostaglandins Leukot. Essent. Fatty Acids. 66:2002;269-285.
33. Liu Y.B., Disterhoft J.F., Slater N.T. Activation of metabotropic glutamate receptors induces long-term depression of GABAergic inhibition in hippocampus. J. Neurophysiol. 69:1993;1000-1004.
34. Lu Y.M., Mansuy I.M., Kandel E.R., Roder J. Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. Neuron. 26:2000;197-205.
35. Maejima T., Hashimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron. 31:2001;463-475.
36. Malenka R.C., Nicoll R.A. Long-term potentiation - a decade of progress? Science. 285:1999;1870-1874.
37. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgansberger W.et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 418:2002;530-534.
38. Martin S.J., Grimwood P.D., Morris R.G. Synaptic plasticity and memory. an evaluation of the hypothesis Annu. Rev. Neurosci. 23:2000;649-711.
39. McBain C.J., Fisahn A. Interneurons unbound. Nat. Rev. Neurosci. 2:2001;11-23.
40. Mechoulam R., Fride E., Di Marzo V. Endocannabinoids. Eur. J. Pharmacol. 359:1998;1-18.
41. Miles R., Toth K., Gulyas A.I., Hajos N., Freund T.F. Differences between somatic and dendritic inhibition in the hippocampus. Neuron. 16:1996;815-823.
42. Misner D.L., Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 19:1999;6795-6805.
43. Ohno-Shosaku T., Shosaku J., Tsubokawa H., Kano M. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur. J. Neurosci. 15:2002;953-961.
44. Ouardouz M., Sastry B.R. Mechanisms underlying LTP of inhibitory synaptic transmission in the deep cerebellar nuclei. J. Neurophysiol. 84:2000;1414-1421.
45. Pawelzik H., Hughes D.I., Thomson A.M. Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus. J. Comp. Neurol. 443:2002;346-367.
46. Pertwee R.G., Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids. 66:2002;101-121.
47. Pitler T.A., Alger B.E. Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J. Neurosci. 12:1992;4122-4132.
48. Poncer J.C., Shinozaki H., Miles R. Dual modulation of synaptic inhibition by distinct metabotropic glutamate receptors in the rat hippocampus. J. Physiol. 485:1995;121-134.
49. Prescott S.M., Majerus P.W. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J. Biol. Chem. 258:1983;764-769.
50. Prince D.A. Neurophysiology of epilepsy. Annu. Rev. Neurosci. 1:1978;395-415.
51. Robbe D., Kopf M., Remaury A., Bockaert J., Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA. 99:2002;8384-8388.
52. Romero J., Garcia L., Fernandez-Ruiz J.J., Cebeira M., Ramos J.A. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 51:1995;731-737.
53. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22:2001;565-572.
54. Shew T., Yip S., Sastry B.R. Mechanisms involved in tetanus-induced potentiation of fast IPSCs in rat hippocampal CA1 neurons. J. Neurophysiol. 83:2000;3388-3401.
55. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 17:1997;7503-7522.
56. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
57. Stelzer A., Slater N.T., ten Bruggencate G. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy. Nature. 326:1987;698-701.
58. Stelzer A., Simon G., Kovacs G., Rai R. Synaptic disinhibition during maintenance of long-term potentiation in the CA1 hippocampal subfield. Proc. Natl. Acad. Sci. USA. 91:1994;3058-3062.
59. Sugiura T., Kobayashi Y., Oka S., Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids. 66:2002;173-192.
60. Sullivan J.M. Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn. Mem. 7:2000;132-139.
61. Takahashi K.A., Linden D.J. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. J. Neurophysiol. 83:2000;1167-1180.
62. Terranova J.P., Michaud J.C., Le Fur G., Soubrie P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2. reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors Naunyn Schmiedebergs Arch. Pharmacol. 352:1995;576-579.
63. Tsou K., Mackie K., Sanudo-Pena M.C., Walker J.M. Cannabinoid CB1 receptors are localized primarily on cholecystokinin- containing GABAergic interneurons in the rat hippocampal formation. Neuroscience. 93:1999;969-975.
64. Vaughan C.W., McGregor I.S., Christie M.J. Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br. J. Pharmacol. 127:1999;935-940.
65. Wang J.H., Stelzer A. Shared calcium signaling pathways in the induction of long-term potentiation and synaptic disinhibition in CA1 pyramidal cell dendrites. J. Neurophysiol. 75:1996;1687-1702.
66. Wigstrom H., Gustafsson B. Facilitation of hippocampal long-lasting potentiation by GABA antagonists. Acta Physiol. Scand. 125:1985;159-172.
67. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 410:2001;588-592.
68. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science. 296:2002;678-682.